Your browser doesn't support javascript.
loading
Hydroxyurea Use After Transitions of Care Among Young Adults With Sickle Cell Disease and Tennessee Medicaid Insurance.
Mathias, Joacy G; Nolan, Vikki G; Klesges, Lisa M; Badawy, Sherif M; Cooper, William O; Hankins, Jane S; Smeltzer, Matthew P.
Afiliação
  • Mathias JG; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill.
  • Nolan VG; Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, The University of Memphis, Memphis, Tennessee.
  • Klesges LM; Department of Surgery, Washington University School of Medicine, St Louis, Missouri.
  • Badawy SM; Division of Hematology, Oncology, Neuro-Oncology, and Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
  • Cooper WO; Department of Pediatrics, Vanderbilt University, Nashville, Tennessee.
  • Hankins JS; Department of Health Policy, Vanderbilt University, Nashville, Tennessee.
  • Smeltzer MP; Department of Hematology, St Jude Children's Research Hospital, Memphis, Tennessee.
JAMA Netw Open ; 4(10): e2128971, 2021 10 01.
Article em En | MEDLINE | ID: mdl-34643722

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicaid / Hidroxiureia / Anemia Falciforme Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicaid / Hidroxiureia / Anemia Falciforme Idioma: En Ano de publicação: 2021 Tipo de documento: Article